Literature DB >> 12196343

Accumulation of foam cells in liver X receptor-deficient mice.

Gertrud U Schuster1, Paolo Parini, Ling Wang, Siegfried Alberti, Knut R Steffensen, Göran K Hansson, Bo Angelin, Jan-Ake Gustafsson.   

Abstract

BACKGROUND: The nature of some of the target genes for liver X receptors (LXRs)-alpha and -beta, such as sterol regulatory element binding protein-1 and ATP-binding cassette transporter proteins, suggests a pivotal role of these nuclear receptors in the regulation of fatty acid and cholesterol homeostasis. The present study aimed to elucidate the physiological relevance of both LXRs with regard to lipid metabolism and macrophage cholesterol efflux. METHODS AND
RESULTS: Mice depleted for LXRalpha, LXRbeta, or both were fed low-fat rodent chow for 18 months before investigations. The combined deficiency of LXRalpha and LXRbeta was linked to impaired triglyceride metabolism, increased LDL and reduced HDL cholesterol levels, and cholesterol accumulation in macrophages (foam cells) of the spleen, lung, and arterial wall.
CONCLUSIONS: Our data demonstrate the physiological importance of both LXRs in lipid metabolism and strongly indicate that both LXRs have a protective role against the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196343     DOI: 10.1161/01.cir.0000026802.79202.96

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

Review 1.  Liver X receptors, atherosclerosis and inflammation.

Authors:  Daryn R Michael; Tim G Ashlin; Melanie L Buckley; Dipak P Ramji
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 2.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

3.  The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.

Authors:  Gurdeep Marwarha; Turk Rhen; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2011-10-24       Impact factor: 5.372

4.  Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.

Authors:  Christian Bindesbøll; Qiong Fan; Rikke C Nørgaard; Laura MacPherson; Hai-Bin Ruan; Jing Wu; Thomas Å Pedersen; Knut R Steffensen; Xiaoyong Yang; Jason Matthews; Susanne Mandrup; Hilde I Nebb; Line M Grønning-Wang
Journal:  J Lipid Res       Date:  2015-02-27       Impact factor: 5.922

Review 5.  Liver X receptors as integrators of metabolic and inflammatory signaling.

Authors:  Noam Zelcer; Peter Tontonoz
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

6.  Mycolates of Mycobacterium tuberculosis modulate the flow of cholesterol for bacillary proliferation in murine macrophages.

Authors:  Ilke Vermeulen; Mark Baird; Juma Al-Dulayymi; Muriel Smet; Jan Verschoor; Johan Grooten
Journal:  J Lipid Res       Date:  2017-02-13       Impact factor: 5.922

7.  Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol.

Authors:  Aicha Saadane; Natalia Mast; Casey D Charvet; Saida Omarova; Wenchao Zheng; Suber S Huang; Timothy S Kern; Neal S Peachey; Irina A Pikuleva
Journal:  Am J Pathol       Date:  2014-07-25       Impact factor: 4.307

Review 8.  Minireview: liver X receptor beta: emerging roles in physiology and diseases.

Authors:  Chiara Gabbi; Margaret Warner; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2008-12-12

Review 9.  Are side-chain oxidized oxysterols regulators also in vivo?

Authors:  Ingemar Björkhem
Journal:  J Lipid Res       Date:  2008-10-23       Impact factor: 5.922

10.  Liver x receptor: a novel therapeutic target.

Authors:  M B Patel; N A Oza; I S Anand; S S Deshpande; C N Patel
Journal:  Indian J Pharm Sci       Date:  2008 Mar-Apr       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.